203 related articles for article (PubMed ID: 28444326)
1. Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.
Garcia R; Cotter AR; Leslie K; Olive MF; Neisewander JL
Int J Neuropsychopharmacol; 2017 Aug; 20(8):644-653. PubMed ID: 28444326
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence for an abstinence-induced switch in 5-HT1B receptor modulation of cocaine self-administration and cocaine-seeking behavior.
Pentkowski NS; Harder BG; Brunwasser SJ; Bastle RM; Peartree NA; Yanamandra K; Adams MD; Der-Ghazarian T; Neisewander JL
ACS Chem Neurosci; 2014 Mar; 5(3):168-76. PubMed ID: 24369697
[TBL] [Abstract][Full Text] [Related]
3. Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats.
Przegaliński E; Gołda A; Frankowska M; Zaniewska M; Filip M
Eur J Pharmacol; 2007 Mar; 559(2-3):165-72. PubMed ID: 17291490
[TBL] [Abstract][Full Text] [Related]
4. 5-HT
Scott SN; Garcia R; Powell GL; Doyle SM; Ruscitti B; Le T; Esquer A; Blattner KM; Blass BE; Neisewander JL
J Psychopharmacol; 2021 Oct; 35(10):1216-1225. PubMed ID: 34049460
[TBL] [Abstract][Full Text] [Related]
5. Preclinical support for the therapeutic potential of zolmitriptan as a treatment for cocaine use disorders.
Garcia R; Le T; Scott SN; Charmchi D; Sprout JML; Pentkowski NS; Neisewander JL
Transl Psychiatry; 2020 Aug; 10(1):266. PubMed ID: 32747623
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.
Neisewander JL; Cheung TH; Pentkowski NS
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):301-19. PubMed ID: 23973315
[TBL] [Abstract][Full Text] [Related]
7. Effects of serotonin (5-HT)1B receptor ligands on amphetamine-seeking behavior in rats.
Miszkiel J; Przegaliński E
Pharmacol Rep; 2013; 65(4):813-22. PubMed ID: 24145075
[TBL] [Abstract][Full Text] [Related]
8. Firing characteristics of deep dorsal horn neurons after acute spinal transection during administration of agonists for 5-HT1B/1D and NMDA receptors.
Thaweerattanasinp T; Heckman CJ; Tysseling VM
J Neurophysiol; 2016 Oct; 116(4):1644-1653. PubMed ID: 27486104
[TBL] [Abstract][Full Text] [Related]
9. RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors.
Fletcher PJ; Korth KM
Behav Pharmacol; 1999 Mar; 10(2):183-93. PubMed ID: 10780831
[TBL] [Abstract][Full Text] [Related]
10. Olfactory bulbectomy increases reinstatement of methamphetamine seeking after a forced abstinence in rats.
Babinska Z; Ruda-Kucerova J; Amchova P; Merhautova J; Dusek L; Sulcova A
Behav Brain Res; 2016 Jan; 297():20-7. PubMed ID: 26431766
[TBL] [Abstract][Full Text] [Related]
11. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.
Pittenger ST; Barrett ST; Chou S; Bevins RA
Behav Brain Res; 2016 Mar; 300():150-9. PubMed ID: 26638833
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model.
Caprioli D; Venniro M; Zeric T; Li X; Adhikary S; Madangopal R; Marchant NJ; Lucantonio F; Schoenbaum G; Bossert JM; Shaham Y
Biol Psychiatry; 2015 Oct; 78(7):463-73. PubMed ID: 25861699
[TBL] [Abstract][Full Text] [Related]
13. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats.
Pittenger ST; Barrett ST; Chou S; Bevins RA
Behav Brain Res; 2017 Mar; 320():195-199. PubMed ID: 27939341
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats.
Carson DS; Cornish JL; Guastella AJ; Hunt GE; McGregor IS
Neuropharmacology; 2010 Jan; 58(1):38-43. PubMed ID: 19560473
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats.
Hay GL; Baracz SJ; Everett NA; Roberts J; Costa PA; Arnold JC; McGregor IS; Cornish JL
J Psychopharmacol; 2018 Dec; 32(12):1369-1378. PubMed ID: 30260267
[TBL] [Abstract][Full Text] [Related]
16. Neural Circuits Associated with 5-HT
Der-Ghazarian TS; Charmchi D; Noudali SN; Scott SN; Holter MC; Newbern JM; Neisewander JL
ACS Chem Neurosci; 2019 Jul; 10(7):3271-3283. PubMed ID: 31042352
[TBL] [Abstract][Full Text] [Related]
17. Zolmitriptan--a 5-HT1B/D agonist, alcohol, and aggression in mice.
de Almeida RM; Nikulina EM; Faccidomo S; Fish EW; Miczek KA
Psychopharmacology (Berl); 2001 Sep; 157(2):131-41. PubMed ID: 11594437
[TBL] [Abstract][Full Text] [Related]
18. A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Hiranita T; Yamamoto T; Nawata Y
Neuroscience; 2010 Jan; 165(2):300-12. PubMed ID: 19883738
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251.
Vinklerová J; Nováková J; Sulcová A
J Psychopharmacol; 2002 Jun; 16(2):139-43. PubMed ID: 12095072
[TBL] [Abstract][Full Text] [Related]
20. Effects of the serotonin 2C receptor agonist WAY163909 on the abuse-related effects and mesolimbic dopamine neurochemistry induced by abused stimulants in rhesus monkeys.
Berro LF; Perez Diaz M; Maltbie E; Howell LL
Psychopharmacology (Berl); 2017 Sep; 234(17):2607-2617. PubMed ID: 28584928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
